-
341por Hulten, Kristina G, Barson, William, Lin, P Ling, Bradley, John S, Peters, Timothy R, Tan, Tina Q, Romero, Jose R, Pannaraj, Pia S, Kaplan, Sheldon LEnlace del recurso
Publicado 2020
Enlace del recurso
Online Artículo Texto -
342por Jespersen, Simon Imer, Demant, Malene Nøhr, Pedersen, Michael Lynge, Homøe, PrebenEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343por Nisar, Muhammad Imran, Ahmed, Sheraz, Jehan, Fyezah, Shahid, Shahira, Shakoor, Sadia, Kabir, Furqan, Hotwani, Aneeta, Munir, Sahrish, Muhammad, Sajid, Khalid, Farah, Althouse, Benjamin, Hu, Hao, Whitney, Cynthia, Ali, Asad, Zaidi, Anita K.M., Omer, Saad B., Iqbal, NajeehaEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344
-
345“…Almost two-thirds of patients (1373/2177) declared having been vaccinated during the 2019/2020 influenza season, and 41% (894/2177) were certain about being up to date with the pneumococcal vaccination. The main barriers to vaccination for influenza are the fear of side effects, doubt regarding the efficacy of the vaccine and for pneumococcal vaccination, and the absence of suggestions by the healthcare professionals (HCPs), as 64% of respondents were not recommended to obtain pneumococcal vaccination. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
346por Suitner, Caterina, Salvador Casara, Bruno Gabriel, Maggi, Stefania, Baldo, Vincenzo“…Participants’ self-reported pneumococcal vaccination status, vaccine literacy, information source, and risk perception related to the infection and to vaccines-adverse reactions were assessed. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
347
-
348por Yang, Yuan, Zhang, Ting, Wang, Yan, Ma, Libing, Xie, Shuyun, Zhou, Jian, Qi, Weiran, Wang, Qing, Dai, Peixi, Du, Yuanze, Feng, Luzhao, Wang, Chunping, Yang, Weizhong“…Vaccination is the most cost-effective intervention to prevent PDs, but pneumococcal vaccines coverage among children is low in China. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
349por Li, Linqiao, Ma, Yuan, Li, Wei, Tang, Guorong, Jiang, Yan, Li, Huangcui, Jiang, Shuxiang, Zhou, Yun, Yang, Yuan, Zhang, Ting, Yang, Weizhong, Ma, Libing, Feng, LuzhaoEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
350por Hansen, Karin, Rünow, Elisabeth, Torisson, Gustav, Theilacker, Christian, Palmborg, Andreas, Pan, Kaijie, Jiang, Qin, Southern, Jo, Beavon, Rohini, Gessner, Bradford D., Riesbeck, Kristian, Ahl, Jonas“…CONCLUSION: Compared to earlier pneumococcal vaccines, PCV20 expands the coverage of all-cause CAP. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
351por Addario, Alexandra, Célarier, Thomas, Bongue, Bienvenu, Barth, Nathalie, Gavazzi, Gaëtan, Botelho-Nevers, Elisabeth“…We retrieved 38 studies (influenza vaccine = 33, pneumococcal vaccine = 5, and zoster vaccine = 2). A total of 28 and 2 studies have shown that influenza and pneumococcal vaccines significantly lower the risk of cardiovascular disease in the elderly. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
352“…Therefore, we investigated GPs’ awareness and drivers of and barriers to pneumococcal vaccination using a cross-sectional web-based survey of GPs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
353
-
354por Vila-Córcoles, Angel, Ochoa-Gondar, Olga, Ester, Francisco, Sarrá, Nuria, Ansa, Xabier, Saún, Neus“…BACKGROUND: The systematic vaccination with 23-valent polysaccharide pneumococcal vaccine (PPV) was introduced as a strategic objective of health for all the people over 65 in Catalonia in 1999. …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
355
-
356“…METHODS: A decision-analytic model was employed to evaluate the impact of a 7-valent pneumococcal vaccine (PCV7) infant vaccination program on the incidence, mortality, and cost associated with pneumococcal disease during a typical influenza season (15 % flu incidence) and influenza pandemic (30 % flu incidence) in China. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
357“…This study aimed to assess the impact of belimumab on immune response to pneumococcal vaccination in patients with systemic lupus erythematosus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
358
-
359por Sakamoto, Akihiro, Chanyasanha, Charnchudhi, Sujirarat, Dusit, Matsumoto, Nobuhiro, Nakazato, Masamitsu“…All elderly people aged 65 years or older are recommended to receive a pneumococcal vaccine. A subsidy for part of the cost of routine pneumococcal vaccination in this age group was introduced in 2014. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
360“…This study examined factors associated with influenza (flu) and pneumococcal vaccination rates among non-Hispanic black, Hispanic, and Asian American adults aged 50 or older living in New York City or Los Angeles and Orange counties in California. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto